Comparing a straight-to-biopsy versus pleural aspiration-first approach in malignant and tuberculous pleural effusions
Therapeutic Advances in Respiratory Disease · 2026
DOI: 10.1177/17534666261500333 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2026. Verfasst von Ken Junyang Goh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Pleural Effusion, Malignant, Tuberculosis, Pleural, Thoracentesis. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Pleural aspiration has limited diagnostic yield in malignant (MPE) and tuberculous pleural effusions (TPE), more so when requiring molecular profiling in MPE and due to the paucibacillary nature of TPE. In our institution, patients with suspected MPE or TPE are offered a straight-to-biopsy approach with pleural biopsy as the initial diagnostic procedure, or a pleural aspiration-first approach, through shared decision-making.
Objectives
To compare clinical outcomes between a straight-to-biopsy strategy and a pleural aspiration-first approach in patients diagnosed with MPE or TPE.
Design
We performed a retrospective study of patients who underwent pleural procedures for unilateral effusions between January 2022 and February 2025 and were diagnosed with MPE or TPE. We excluded patients with an Eastern Cooperative Oncology Group status ≥ 3 and patients with a pre-existing, established diagnosis of metastatic cancer who had pleural procedures performed for non-diagnostic intent.
Methods
Clinical outcomes were compared between a straight-to-biopsy versus pleural aspiration-first approach.
Results
271 patients were included (mean age 67 years, SD 15); 74.9% had MPE and 25.1% had TPE. Straight-to-biopsy and pleural aspiration-first approaches were undertaken in 44.3% and 55.7% of patients, respectively. Most patients in the straight-to-biopsy group underwent medical thoracoscopy (92.5%, 111/120), with concurrent talc pleurodesis performed in 55 patients. Compared with pleural aspiration-first, a straight-to-biopsy approach was associated with a shorter time to actionable diagnosis (16 (IQR:9-21) vs 23 (IQR:16-40) days; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.
- Oxford Respiratory Trials Unit, University of Oxford, Oxford, UK.
- Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, UK.
ORCID-Profile: Ken Junyang Goh
Zitieren
APA
Goh, K. J., Tang, K. J. Y., Chia, N. A. M. E., Chua, B. L. W., Tan, Q. L., Rahman, N. M., & Young, S. L. (2026). Comparing a straight-to-biopsy versus pleural aspiration-first approach in malignant and tuberculous pleural effusions. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666261500333
Vancouver
Goh KJ, Tang KJY, Chia NAME, Chua BLW, Tan QL, Rahman NM, et al. Comparing a straight-to-biopsy versus pleural aspiration-first approach in malignant and tuberculous pleural effusions. Therapeutic Advances in Respiratory Disease. 2026. doi:10.1177/17534666261500333
BibTeX
@article{Goh2026,
author = {Goh, Ken Junyang and Tang, Kendra Jing Ying and Chia, Nicole Ashley Min En and Chua, Brian Lee Wei and Tan, Qiao Li and Rahman, Najib M and Young, Si Ling},
title = {Comparing a straight-to-biopsy versus pleural aspiration-first approach in malignant and tuberculous pleural effusions},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2026},
doi = {10.1177/17534666261500333}
}
EUVIMED